Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression

Journal of Neuroimmunology

Volumn 260, Issue 1-2, 2013, Pages 1-8

  Yongjun, Yi ^a   Shuyun, Huang ^a   Lei, Chen ^a   Xiangrong, Chen ^a,b   Zhilin, Yang ^a   Yiquan, Ke ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Atorvastatin; Glioma; Invasion; Microglia; Migration; MT1 MMP

Indexed keywords

ATORVASTATIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; GLIOMA CELL; HUMAN; HUMAN CELL; MICROGLIA; MIGRATION INHIBITION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MICROGLIA; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRROLES;

EID: 84878632932     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.04.020     Document Type: Article

References (28)

1. Chandrasekar B., Mummidi S., Mahimainathan L., Patel D.N., Bailey S.R., Imam S.Z., Greene W.C., Valente A.J. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J. Biol. Chem. 2006, 281:15099-15109.
2. Chen J., Hou J., Zhang J., An Y., Zhang X., Yue L., Liu J., Li X. Atorvastatin synergizes with IFN-gamma in treating human non-small cell lung carcinomas via potent inhibition of RhoA activity. Eur. J. Pharmacol. 2012, 682:161-170.
3. Chen J., Lan T., Hou J., Zhang J., An Y., Tie L., Pan Y., Liu J., Li X. Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1. Int. J. Biochem. Cell Biol. 2012, 44:759-769.
4. Collisson E.A., Kleer C., Wu M., De A., Gambhir S.S., Merajver S.D., Kolodney M.S. Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells. Mol. Cancer Ther. 2003, 2:941-948.
5. Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006, 25:9-34.
6. Fonseca A.C., Romao L., Amaral R.F., Assad K.S., Lobo D., Martins S., Marcondes D.S.J., Moura-Neto V., Lima F.R. Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells. Neuroscience 2012, 200:130-141.
7. Fromigue O., Hamidouche Z., Marie P.J. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J. Biol. Chem. 2008, 283:30549-30556.
8. Gliemroth J., Zulewski H., Arnold H., Terzis A.J. Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin. Neurosurg. Rev. 2003, 26:117-124.
9. Guo P., Imanishi Y., Cackowski F.C., Jarzynka M.J., Tao H.Q., Nishikawa R., Hirose T., Hu B., Cheng S.Y. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am. J. Pathol. 2005, 166:877-890.
10. He Z., Mangala L.S., Theriot C.A., Rohde L.H., Wu H., Zhang Y. Cell killing and radiosensitizing effects of atorvastatin in PC3 prostate cancer cells. J. Radiat. Res. 2012, 53:225-233.
11. Izidoro-Toledo T.C., Guimaraes D.A., Belo V.A., Gerlach R.F., Tanus-Santos J.E. Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch. Pharmacol. 2011, 383:547-554.
12. Lafuente J.V., Adan B., Alkiza K., Garibi J.M., Rossi M., Cruz-Sanchez F.F. Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. J. Mol. Neurosci. 1999, 13:177-185.
13. Lai W.C., Zhou M., Shankavaram U., Peng G., Wahl L.M. Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Immunol. 2003, 170:6244-6249.
14. Lee Y., Kim H., Kim S., Kim K.H., Chung J.H. Activation of toll-like receptors 2, 3 or 5 induces matrix metalloproteinase-1 and -9 expression with the involvement of MAPKs and NF-kappaB in human epidermal keratinocytes. Exp. Dermatol. 2010, 19:e44-e49.
15. Mahajan N., Dhawan V. Inhibition of C-reactive protein induced expression of matrix metalloproteinases by atorvastatin in THP-1 cells. Mol. Cell. Biochem. 2010, 338:77-86.
16. Maquoi E., Frankenne F., Baramova E., Munaut C., Sounni N.E., Remacle A., Noel A., Murphy G., Foidart J.M. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines. J. Biol. Chem. 2000, 275:11368-11378.
17. Markovic D.S., Glass R., Synowitz M., Rooijen N., Kettenmann H. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol. 2005, 64:754-762.
18. Markovic D.S., Vinnakota K., Chirasani S., Synowitz M., Raguet H., Stock K., Sliwa M., Lehmann S., Kalin R., van Rooijen N., Holmbeck K., Heppner F.L., Kiwit J., Matyash V., Lehnardt S., Kaminska B., Glass R., Kettenmann H. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12530-12535.
19. Murai T., Maruyama Y., Mio K., Nishiyama H., Suga M., Sato C. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J. Biol. Chem. 2011, 286:1999-2007.
20. Obara S., Nakata M., Takeshima H., Kuratsu J., Maruyama I., Kitajima I. Inhibition of migration of human glioblastoma cells by cerivastatin in association with focal adhesion kinase (FAK). Cancer Lett. 2002, 185:153-161.
21. Ohgaki H., Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J. Neuropathol. Exp. Neurol. 2005, 64:479-489.
22. Ohgaki H., Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005, 109:93-108.
23. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 2003, 3:489-501.
24. Reuben P.M., Cheung H.S. Regulation of matrix metalloproteinase (MMP) gene expression by protein kinases. Front. Biosci. 2006, 11:1199-1215.
25. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 1995, 270:5331-5338.
26. Tapia-Perez J.H., Kirches E., Mawrin C., Firsching R., Schneider T. Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells. Cancer Chemother. Pharmacol. 2011, 67:1193-1201.
27. Tsai J.C., Goldman C.K., Gillespie G.Y. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J. Neurosurg. 1995, 82:864-873.
28. Ye X.Z., Xu S.L., Xin Y.H., Yu S.C., Ping Y.F., Chen L., Xiao H.L., Wang B., Yi L., Wang Q.L., Jiang X.F., Yang L., Zhang P., Qian C., Cui Y.H., Zhang X., Bian X.W. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J. Immunol. 2012, 189:444-453.